Ayr Wellness Inc. (AYRWF)
(Delayed Data from OTC)
$2.18 USD
+0.03 (1.40%)
Updated Jun 4, 2024 03:57 PM ET
2-Buy of 5 2
A Value B Growth C Momentum A VGM
Brokerage Reports
Ayr Wellness Inc. [AYRWF]
Reports for Purchase
Showing records 41 - 60 ( 92 total )
Company: Ayr Wellness Inc.
Industry: Medical - Products
4Q22 Preview, Execution Focus to Fully Optimize Assets
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: Cannabis Earnings Week 2: Week 1 Takeaways
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis State of the Union: A Year of Resiliency With Focus on 2024
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Announces New CEO, Expect Brand and Retail Operational Improvement
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Terminating IL Dispensary 33 Deal to Focus on Scaled States, PT to $8
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis Industry Update: 2022 Performance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Mid-Term Election Takeaways - With Final Results Still TBD
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Company: Ayr Wellness Inc.
Industry: Medical - Products
3Q22 Inline But Trending Right, Full Optimization in ''23, PT to $12
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis Industry Update: Earnings Week II Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Ayr Wellness Inc.
Industry: Medical - Products
Q3 Fundamentals Appear Soft but Legislative Reform Looks Promising
Provider: VENTUM CAPITAL MARKETS
Analyst: ZANDBERG J
Company: Ayr Wellness Inc.
Industry: Medical - Products
Cannabis Industry Update: 3Q22 Earnings - Week I Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department